The influence of initial peritoneal transport characteristics, inflammation, and high glucose exposure on prognosis for peritoneal membrane function

Peritoneal Dialysis International

Volumn 32, Issue 6, 2012, Pages 636-644

  Jose Fernandez Reyes M ^b   Auxiliadora Bajo, M ^a   Del Peso, Gloria ^a   Ossorio, Marta ^a   Díaz, Raquel ^a   Carretero, Beatriz ^a   Selgas, Rafael ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL GENERAL DE SEGOVIA   (Spain)

Author keywords

Bioincompatible solution; Peritoneal transport outcome; Peritonitis

Indexed keywords

CREATININE; GLUCOSE; ICODEXTRIN; UREA;

ADULT; AGED; ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GLUCOSE ASSAY; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MEMBRANE BIOLOGY; MEMBRANE PERMEABILITY; OUTCOME ASSESSMENT; PERITONEAL MEMBRANE; PERITONEUM; PERITONITIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TRANSPORT KINETICS; TREATMENT DURATION; TREATMENT FAILURE; ULTRAFILTRATION;

ADULT; BLOOD GLUCOSE; CREATININE; DIALYSIS SOLUTIONS; FEMALE; GLUCANS; GLUCOSE; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; ULTRAFILTRATION;

EID: 84871018047     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2011.00137     Document Type: Article

References (29)

1. Maiorca R, Vonesh EF, Cavalli P, De Vecchi A, Giangrande A, La Greca G, et al. A multicenter, selection-adjusted comparison of patient and techniques survivals on CAPD and hemodialysis. Perit Dial Int 1991; 11:118-27.
2. Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, Constantini EG, et al. Mortality risk of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999; 34:1065-74.
3. Gokal R, Figueras M, Ollé A, Rovira J, Badia X. Outcomes in peritoneal dialysis and hemodialysis-a comparative assessment of survival and quality of life. Nephrol Dial Transplant 1999; 14(Suppl 6):24-30.
4. Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc nephrol 2010; 21:499-506.
5. Selgas R, Fernandez-Reyes MJ, Bosque E, Bajo MA, Borrego F, Jimenez C, et al. Funtional longevity of human peritoneum-for how long is chronic peritoneal dialysis possible? Results of a prospective medium long-term study. Am J Kidney Dis 1994; 23:64-73.
6. Struijk DG, Krediet RT, Koomen GC, Boeschoten EW, Hoek FJ, Arisz L. A prospective study of peritoneal transport in CAPD patients. Kidney Int 1994; 45:1739-44.
7. Davies SJ, Bryan J, Phillips L, Russell GI. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Dial Transplant 1996; 11:498-506.
8. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc nephrol 2001; 12:1046-51.
9. Davies SJ. Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int 2004; 66:2437-45.
10. Parikova A, Smit W, Struijk DG, Krediet RT. Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure. Kidney Int 2006; 70:1988-94.
11. Del Peso G, Jiménez-Heffernan JA, Bajo MA, Aroeira LS, Aguilera A, Fernández-Perpén A, et al. Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport. Kidney Int Suppl 2008; (108):S26-33.
12. Honda K, Hamada C, Nakayama M, Miyazaki M, Sherif AM, Harada T, et al. Peritoneal biopsy study group of the Japanese Society for Peritoneal Dialysis. Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology. Clin J Am Soc nephrol 2008; 3:720-8.
13. Kim YL. Update on mechanisms of ultrafiltration failure. Perit Dial Int 2009; 29(Suppl 2):S123-7.
14. Selgas R, Bajo MA, Cirugeda A, del Peso G, Valdés J, Castro MJ, et al. Ultrafiltration and small solute transport at initiation of PD: questioning the paradigm of peritoneal function. Perit Dial Int 2005; 25:68-76.
15. Reyes MJ, Bajo MA, Hevía C, Del Peso G, Ros S, de Miguel AG, et al. Inherent high peritoneal transport and ultra-filtration deficiency: their mid-term clinical relevance. Nephrol Dial Transplant 2007; 22:218-23.
16. Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG. Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 2006; 17:2591-8.
17. del Peso G, Fernández-Reyes MJ, Hevia C, Bajo MA, Castro MJ, Cirugeda A, et al. Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: peritonitis is the main factor. Nephrol Dial Transplant 2005; 20:1201-6.
18. Lo WK, Brendolan A, Prowant BF, Moore HL, Khanna R, Twardowski ZJ, et al. Changes in the peritoneal equilibration test in selected chronic peritoneal dialysis patients. J Am Soc nephrol 1994; 4:1466-74.
19. Chung SH, Heimbürger O, Lindholm B. Poor outcomes for fast transporters on PD: the rise and fall of clinical concern. Semin Dial 2008; 21:7-10.
20. Mujais S, Nolph K, Gokal R, Blake P, Burkart J, Coles G, et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000; 20(Suppl 4):S5-21.
21. Johnson DW, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis. Dial Transplant 2010; 25:1973-9.
22. Yang X, Fang W, Bargman JM, Oreopoulos DG. High peritoneal permeability is not associated with higher mortality or technique failure in patients on automated peritoneal dialysis. Perit Dial Int 2008; 28:82-92.
23. Cho JH, Hur IK, Kim CD, Park SH, Ryu HM, Yook JM, et al. Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study. Nephrol Dial Transplant 2010; 25:1964-73.
24. Selgas R, Paiva A, Bajo MA, Cirugeda A, Aguilera A, Díaz C, et al. Consequences of peritonitis episodes appearing late during peritoneal dialysis (PD) in patients able to continue PD. Adv Perit Dial 1998; 14:168-72.
25. De Vriese AS, Flyvbjerg A, Mortier S, Tilton RG, Lameire NH. Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane. J Am Soc 2003; 14:2109-18.
26. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, et al. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 1997; 51:182-6.
27. Kim CD, Kwon HM, Park SH, Oh EJ, Kim MH, Choi SY, et al. Effect of low glucose degradation products peritoneal dialysis fluid on peritoneal fibrosis and vasculation in a chronic rats model. Ther Apher Dial 2007; 11:56-64.
28. Fernández-Reyes MJ, Bajo MA, del Peso G, Olea T, Sánchez-Villanueva RL, González E, et al. Effect of using icodextrin as a starting therapy for peritoneal permeability [Spanish]. Nefrologia 2009; 29:130-5.
29. Davies SJ, Brown EA, Frandsen NE, Rodrigues AS, Rodriguez-Carmona A, Vychytil A, et al. Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription. Kidney Int 2005; 67:1609-15.